课题基金 / 基金详情

Systems Biochemistry in Lung Cancer: Toward a Mechanistic Understanding of NSCLC

Systems Biochemistry in Lung Cancer: Toward a Mechanistic Understanding of NSCLC
肺癌的系统生物化学:了解非小细胞肺癌的机制
批准号:
9235136
负责人:
Teresa Whei-Mei Fan
金额:
$126.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-19 至 2020-02-29
关键词:
AddressAnalytical BiochemistryAnimal ModelAnimalsArginineBenignBiochemicalBiochemical PathwayBiochemistryBioinformaticsBiometryCancer BiologyCell Culture TechniquesCell modelCellsCessation of lifeClinical TrialsCollaborationsCongressesDataDeath RateDetectionDevelopmentDiseaseEarly DiagnosisEpithelial CellsFibroblastsFood InteractionsFutureGenerationsGenesGlucansGlucoseGlutamineGoalsHumanHypoxiaImmuneImmune systemImmunomodulatorsImplantIn SituIndividualInformaticsInvestigationKnowledgeLabelLaboratoriesLinkLungLung NeoplasmsMacrophage ActivationMalignant NeoplasmsMalignant neoplasm of lungMass Spectrum AnalysisMediatingMetabolicMetabolic PathwayMetabolismModelingMolecularMusMutation AnalysisNatural ProductsNatureNon-Small-Cell Lung CarcinomaNorth AmericaNutrientPathway AnalysisPatientsPatternPhysiciansPlasmaProcessPropertyProteomicsRefractoryResectedResolutionRiskRoleSamplingScientistSliceStructure of parenchyma of lungStudy SubjectSurvival RateSystemTechnologyTestingThinnessTimeTissuesTumor-DerivedXenograft procedurearginasebasebeta-Glucanscancer cellcancer subtypescell transformationcohortexosomeexperimental studyhost neoplasm interactionhuman subjecthuman tissueimmune activationimmunoregulationimprovedinsightinterestlung xenograftmacrophagemetabolic phenotypemetabolomicsmouse modelneoplastic cellnovel strategiesoncologyoutcome forecastpre-clinicalprogramsresponsestable isotopesubcutaneoustooltranscriptomicstreatment strategytumortumor immunologytumor metabolismtumor microenvironmenttumor progression

项目摘要

项目成果

Teresa Whei-Mei Fan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Deaths from lung cancer are the highest of all cancers in North America and elsewhere and, because of the long incubation time, are likely to remain so for the foreseeable future. Furthermore, although the 5-year survival rate of stage I lung cancer is 60-70%, later stage disease has a very poor prognosis. Accurate detection of asymptomatic early stage lung cancer in individuals at risk is currently unreliable. A better understanding of the basic biochemistry of lung cancers is a prerequisite to mechanism-based reliable early detection of the disease, and to improved approaches to treatment. The very complexity of the transformed cells, and the variable host-tumor interactions, makes the problem refractory to any single approach. A systems biochemistry approach in which lung cancers are studied at the mechanistic level in the laboratory, in mouse models and in human subjects offers the opportunity to address the complexity of cancer development and progression. The use of stable isotope resolved metabolomics provides the necessary direct biochemical information about lung cancer with minimal processing that is not otherwise available. This program will address the problem in a 3-pronged approach, based on the following integrated projects: Project 1: Cellular Systems Biochemistry. Microenvironmental nutrient availability and immune modulation in lung cancer cells. Project 2; Preclinical Systems Biochemistry. Using SIRM in Human NSCLC xenograft mouse to determine biochemical mechanisms of immunomodulator ¿-glucan. Project 3: Translational Systems Biochemistry. Molecular mechanisms of NSCLC and response to ¿-glucan by SIRM. The three projects will use a common mechanistic approach to understanding cancer biochemistry namely stable isotope resolved metabolomics (SIRM) that we have been developing over the last eight years. The analytical requirements will be met in the SIRM Analytical Core, which also supplies the necessary sample handling and bioinformatics support for the three projects. Core A provides overall administrative support.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Mitochondrial Metabolic Reprogramming and DNA Damage in Arsenic Carcinogenesis
  • 批准号:
    9090111
  • 项目类别:
  • 资助金额:
    $22.47万
  • 财政年份:
    2015
  • 负责人:
    Teresa Whei-Mei Fan
  • 依托单位:
Mitochondrial Metabolic Reprogramming and DNA Damage in Arsenic Carcinogenesis
  • 批准号:
    8927921
  • 项目类别:
  • 资助金额:
    $18.81万
  • 财政年份:
    2015
  • 负责人:
    Teresa Whei-Mei Fan
  • 依托单位:
Determining Tumor Metabolism and Biochemical Mechanism of beta-glucan Action in
  • 批准号:
    8744923
  • 项目类别:
  • 资助金额:
    $26.15万
  • 财政年份:
    2014
  • 负责人:
    Teresa Whei-Mei Fan
  • 依托单位:
Integrated Chemoselective and Informatic Platform for Large-Scale Metabolomics
  • 批准号:
    8914844
  • 项目类别:
  • 资助金额:
    $44.36万
  • 财政年份:
    2014
  • 负责人:
    Teresa Whei-Mei Fan
  • 依托单位:
海外基金